Ion AmpliSeq reagents
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) has issued a Notice of Intent to award a Firm-Fixed-Price Purchase Order to Life Technologies Corporation for Ion AmpliSeq reagents. These reagents are essential for the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to conduct research on transcriptional biomarkers in individuals with Alcohol Use Disorder. This is not a request for competitive quotes, but small businesses capable of meeting the requirement are invited to submit capability statements. Responses are due by June 24, 2026.
Purpose & Background
The NIH, specifically the NIAAA, requires Ion AmpliSeq reagents to advance research into the impact of alcohol use on human health. These reagents are critical for identifying transcriptional biomarkers in individuals with Alcohol Use Disorder. An ongoing pilot study faced issues with sample and data transfer using a proprietary sequencing method. AmpliSeq is proposed as an alternative due to its low RNA input requirement and ability to handle degraded samples, which is vital for validating existing data and expanding the study dataset.
Contract Details
- Type: Firm-Fixed-Price Purchase Order (intended sole-source)
- Intended Awardee: Life Technologies Corporation
- Product/Service: Ion AmpliSeq reagents (Product Service Code: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)
- Place of Performance: Rockville, MD 20852, United States
- Anticipated Award: Approximately ten (10) days after the notice date, unless another vendor demonstrates capability.
Submission & Eligibility
This notice is not a request for competitive quotes or proposals. However, small businesses (including 8(a), service-disabled veteran-owned, HUBZone, small disadvantaged, veteran-owned, and women-owned small businesses) that believe they can fulfill this requirement are encouraged to submit a written capability statement. This statement should clearly demonstrate their ability to perform the work.
Response Deadline
Capability statements must be emailed to David Shen at david.shen@nih.gov no later than 11:00 p.m. EDT on June 24, 2026.